Press review
The essentials of recent medical publications, unpacked by our newsroom into a clear, sourced digest, specialty by specialty.
OncologyCOVID-19 vaccines linked to longer survival in some cancer patients
By Lila Rouland | Published on November 7, 2025 | 3 min readA recent study published in Nature has revealed a surprising and hopeful connection between COVID-19 mRNA vaccines and improved survival outcomes in patients with certain types of cancer. The research, which focused on individuals undergoing immunotherapy for melanoma and non-small-cell lung cancer, found that those who received a COVID-1
OncologyThe real role of diet after prostate cancer: what does the evidence show?
By Lila Rouland | Published on November 6, 2025 | 3 min readLocalized (non-metastatic) prostate cancer affects a large male population and generally carries a good prognosis. However, patients remain at elevated risk of all-cause mortality, often due to comorbidities such as cardiovascular disease. Diet is known to influence the course of many chronic illnesses, but its impact after a prostate can
OncologyProstate cancer and diet: which eating pattern helps with prevention?
By Lila Rouland | Published on November 6, 2025 | 3 min read Prostate cancer is the second most common cancer in men worldwide. Its incidence varies greatly depending on geography, ethnicity, and, most importantly, lifestyle factors, particularly diet. This review explores how fats, proteins, carbohydrates, vitamins, and phytonutrients influence the development and progression of prostate cancer.
OncologyDo vitamins protect against or promote prostate cancer? a matter of source and dosage
By Lila Rouland | Published on November 5, 2025 | 3 min readProstate cancer (PCa) is the fifth leading cause of cancer-related death among men worldwide. While traditional risk factors (age, ethnicity, metabolic syndrome) are well established, the role of vitamins in prostate cancer prevention remains controversial. Some studies suggest a protective effect, while others indicate an increased risk
OncologyCurcumin in prostate cancer: a promising therapy supported by nanotechnology
By Carolina Lima | Published on November 4, 2025 | 3 min readProstate cancer (PCa) remains one of the most prevalent cancers in men worldwide, often progressing to treatment-resistant stages. In recent years, curcumin—a polyphenolic compound derived from Curcuma longa has gained attention for its multi-targeted anticancer properties. A recent systematic review published in BMC Cancer (2025) highli
OncologyPlant-based diets and disease progression in men with prostate cancer
By Lila Rouland | Published on November 4, 2025 | 3 min readProstate cancer is the second most common malignant tumor in men. Despite therapeutic advances, post-diagnostic management remains a major challenge, particularly regarding modifiable factors such as diet. While plant-based foods are known for their role in primary prevention, their impact on disease progression after diagnosis remains un
OncologyOmega-3 fatty acids: a nutritional lever against prostate cancer
By Lila Rouland | Published on November 3, 2025 | 3 min readProstate cancer is the second most common malignant tumor in men and the fifth leading cause of cancer-related death worldwide. Despite therapeutic advances, prevention and mortality reduction strategies remain limited. Among modifiable factors, diet has attracted growing interest. In particular, polyunsaturated omega-3 fatty acids (EPA,
OncologyWhat if intracellular microbes promote metastasis in breast cancer?
By Lila Rouland | Published on October 31, 2025 | 3 min readBreast cancer, the leading cause of cancer-related death among women worldwide, is particularly feared for its ability to spread and form metastases. While tumor and immune factors involved in this process are well established, the role of the tumor microbiome, especially intracellular bacteria, remains largely unexplored. Bacteria have b
OncologyTNBC and the microbiome: bacteria in the crosshairs
By Ana Espino | Published on October 30, 2025 | 3 min readTriple-negative breast cancer (TNBC) is one of the most aggressive and heterogeneous forms of breast cancer. Lacking hormone receptors and HER2 overexpression, it escapes conventional targeted therapies, greatly limiting treatment options. Moreover, despite recent advances in immunotherapy, early relapse rates and mortality remain particula
PsychiatryFeeling seen: how school connectedness can protect adolescent mental health
By Carolina Lima | Published on October 30, 2025 | 3 min readIn today’s fast-paced and often isolating world, the mental health of adolescents is under increasing strain with depression and anxiety becoming alarmingly common among young people. While treatment is important, prevention is key. One promising approach is strengthening the emotional bonds students have with their schools. A recent sys
OncologyFOXC1: The GPS for Capecitabine in TNBC?
By Ana Espino | Published on October 29, 2025 | 3 min readTriple-negative breast cancer (TNBC) is an aggressive form of the disease, often diagnosed in young women, that does not respond to hormone therapy or HER2-targeted treatments. Therapeutic options are mainly limited to cytotoxic chemotherapy, which shows variable efficacy and notable side effects. Among the available agents, capecitabine is
OncologyCamrelizumab + Apatinib: a winning combo against TNBC?
By Ana Espino | Published on October 29, 2025 | 2 min readTriple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer, often affecting younger women. It is characterized by the absence of hormone receptors and HER2 overexpression, as well as a strong propensity for early metastatic relapse—especially within the first few years after diagnosis. Because it is unrespo